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Abstract—The aromatic diacid residue 4,6-dibenzofuranbispropionic acid (1) was designed to nucleate a parallel b-sheet-like
structure in small peptides in aqueous solution via a hydrogen-bonded hydrophobic cluster. Even though a 14-membered ring
hydrogen bond necessary for parallel b-sheet formation is favored in simple amides composed of 1, this hydrogen bonding inter-
action does not appear to be sucient to nucleate parallel b-sheet formation in the absence of hydrophobic clustering between the
dibenzofuran portion of 1 and the hydrophobic side chains of the flanking a-amino acids. The subsequence -hydrophobic residue-1-
hydrophobic residue- is required for folding in the context of a nucleated two-stranded parallel b-sheet structure. In all cases where
the peptidomimetics can fold into two diastereomeric parallel b-sheet structures having dierent hydrogen bonding networks, these
conformations appear to exchange rapidly. The majority of the parallel b-sheet structures evaluated herein undergo linked intra-
molecular folding and self-assembly, aording a fibrillar b-sheet quaternary structure. To unlink folding and assembly, asymmetric
parallel b-sheet structures incorporating N-methylated a-amino acid residues have been synthesized using a new solid phase
approach. Residue 1 facilitates the folding of several peptides described within aording a monomeric parallel b-sheet-like structure
in aqueous solution, as ascertained by a variety of spectroscopic and biophysical methods, increasing our understanding of parallel
b-sheet structure. # 1999 Elsevier Science Ltd. All rights reserved.
Introduction
Attempts to study aspects of the folding and stability of
b-sheet structures using peptides have been hindered by
their inability to fold or their propensity to self-associ-
ate,1–5 although recent progress is notable.6–12 Parallel
b-sheet structures are particularly dicult to form from
simple a-amino acid sequences because of their more
complex topology relative to antiparallel b-sheet struc-
tures.1,5 Several laboratories are developing template
strategies to eect parallel b-sheet formation where the
template facilitates topologically simple intramolecular
folding.13–25 We have previously reported the synthesis
of the 4,6-dibenzofuranbispropionic acid template (1)
designed to nucleate the folding of two stranded parallel
b-sheet structures via a hydrogen-bonded hydrophobic
cluster and here we report on its ecacy in aqueous solu-
tion.26 This template is designed to function analogous
to the 4-(2-aminoethyl)-6-dibenzofuranpropionic acid
template which nucleates antiparallel b-sheet formation
in aqueous solution employing a hydrogen-bonded
hydrophobic cluster as discerned from NMR-based
structural studies.9,27,28 The desired perpendicular
orientation of the dibenzofuran ring system in 1 relative
to the plane of the parallel b-sheet should be stabilized
by hydrophobic interactions between the dibenzofuran
skeleton and the hydrophobic side chains of the a-
amino acid residues that flank 1, Figure 1.9,27,28
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This hydrogen-bonded hydrophobic cluster is expected
to be stable under a variety of conditions and should
facilitate parallel sheet folding once the solution condi-
tions permit long range residue–residue interactions
between strands.9,27,29–31 Generally, the a-amino acid
sequences used in this study were chosen by considering
the b-sheet forming propensity of each residue, the side
chain–side chain interactions which hold the b-strands
together, the amphiphilicity of the sequence, and the
overall charge on the peptide to ensure solubility.4,8,32–37
Several of the peptides incorporating the subsequence
-hydrophobic residue-1-hydrophobic residue- undergo
intramolecular folding followed by self-assembly,
aording a fibrillar structure like those observed in
neurodegenerative diseases.38–41 Unlinking folding and
self-assembly is accomplished by the strategic incor-
poration of N-methylated a-amino acids into the
sequence, an approach used previously.42–44 Symme-
trical peptides incorporating 1 were prepared employing
a traditional solution phase fragment condensation
reaction between the bis-pentafluorophenyl ester 2 and
the corresponding protected peptide fragments.45–48
Asymmetric peptides incorporating 1 were prepared
using the solid phase fragment condensation strategy
outlined in Scheme 1.
Results and Discussion
Synthesis of parallel nucleator 1 and simple amides
based on 1
The synthesis of 1 was performed as described pre-
viously.9,26 Briefly, dibenzofuran was treated with sec-
butyllithium and TMEDA in diethyl ether at ÿ78 C to
aord 4,6-bis-lithiated dibenzofuran. Addition of iodine
to the dianion aords 4,6-diiododibenzofuran in 83%
yield.49 The 4,6-diiododibenzofuran was subjected to a
Heck cross-coupling reaction with ethylacrylate to yield
the 4,6-bis-a,b-unsaturated ethyl ester in 93% yield.50,51
Saponification followed by catalytic hydrogenation
yields the saturated C2 symmetrical diacid 1 in 93%
yield. The diacid was converted to the activated bis-
pentafluorophenyl ester 2 via DCC activation with pen-
tafluorophenol. Simple amides 3 and 4 incorporating
template 1 were synthesized to evaluate the preferred
intramolecular hydrogen bonding patterns in non-
competitive solvents. Benzylamine displacement of the
pentafluorophenyl groups in 2 in the presence of TEA
yields amide 3, (see Scheme 2 for structure). The pre-
paration of amide 4 uses the monoacid monoester deri-
vative 5 reported previously (Scheme 3).9 The acid
functional group was transformed to the acid chloride 6
Figure 1. Molecular graphics representation of -Val-1-Val- demonstrating the hydrogen-bonded hydrophobic cluster conformation. The ethano
linkages in 1 are perpendicular to the dibenzofuran ring facilitating the ideal hydrophobic interactions between the dibenzofuran skeleton and the
Val side chains. The structure represents the lowest energy conformation predicted by molecular dynamics/simulated annealing studies of -Val-1-
Val- in peptide A in aqueous solution: (a) Side view; (b) Top view.
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Scheme 1. General strategy for the synthesis of asymmetrical parallel b-sheets on solid support.
Scheme 2.
Scheme 3.
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and treated with isobutyl amine yielding the monoamide
monoester intermediate 7. The remaining ester group
was hydrolyzed to aord acid 8, which was converted to
the HOBT ester 9 with BOP. The active ester was reac-
ted with cyclohexylamine to aord the asymmetrical
amide 4 (Schemes 2 and 3). Amide 10 was prepared
using an analogous strategy. In addition, the bis-acid
chloride of 1 was reacted with the peptide H-Val-Val-
OMe to synthesize amide 11.
Evaluation of intramolecular hydrogen bonding in
Amides of 1
Intramolecular amide–amide hydrogen bonding was
evaluated employing FT-IR and variable temperature
NMR spectroscopy in a noncompetitive solvent (CH2Cl2)
to probe the potential of amides composed of residue 1
to form a hydrogen bonding pattern compatible with
parallel b-sheet formation. A sharp amide IR band at
3400–3500 cmÿ1 in CH2Cl2 typically corresponds to a
non-hydrogen-bonded N–H, while a broader absorption
band at 3200–3400 cmÿ1 generally corresponds to an
intramolecularly hydrogen-bonded N–H.9,52–56 Variable
temperature NMR studies on acyclic peptides in non-
competitive solvents (e.g. CH2Cl2, CHCl3) reveal that
intramolecularly hydrogen-bonded N–H’s resonate
downfield (7–9 ppm @ 25 C) and typically exhibit a
relatively large temperature dependence of the chemical
shift (ÿ13 ppb Kÿ1) relative to free N–Hs which resonate
upfield (&6 ppm @ 25 C) and exhibit a small (ÿ3ppb
Kÿ1) temperature dependence of the chemical shift.9,52,56
The temperature dependence of the chemical shift is less
reliable than the FT-IR data, e.g. in cyclic systems and
in rare acyclic systems where the enthalpies of the equi-
librating conformations are similar, the temperature
dependencies of the amide NH chemical shift show
opposite trends to those discussed directly above.57
Previous studies on simple amides show that the anti-
parallel dibenzofuran-based template strongly promotes
a 15-membered ring intramolecular hydrogen-bonded
conformation without detectable intermolecular amide–
amide hydrogen bonding in a 1.5mM CH2Cl2 solu-
tion.9,56 In the amides studied here, a 14-membered ring
intramolecular amide–amide hydrogen bond was
anticipated, the type required to initiate parallel b-sheet
formation (Scheme 2). The IR spectra of a 1.5mM
solution of amide 3 in CH2Cl2 reveals absorption bands
at 3441 and 3336 cmÿ1, consistent with the free and
intramolecularly hydrogen-bonded N–H (supplementary
material available upon request from the author). The
variable temperature NMR studies of amide 3 exhibit a
single amide resonance with a temperature dependence
of ÿ4.4 ppb Kÿ1 (d=6.55 ppm @ 25 C) for the two
amide protons in 3 consistent with a dynamic hydrogen-
bonded state where the exchange between the two dia-
stereomeric hydrogen-bonded forms is rapid relative to
the frequency dierence between the amide N–Hs. Since
amide 3 has two amide hydrogens, complicating the
interpretation of the data, amides 4 and 10 having a
single H-bond donor were studied by IR and VT-NMR
methods. Amide 4 exhibits IR bands at 3446 and
3333 cmÿ1 (25 C) and is characterized by an inter-
mediate temperature dependence (ÿ8.2 ppb/K) of the
N–H chemical shift (Fig. 2) consistent with an equili-
brium between hydrogen-bonded and the non-hydrogen-
bonded conformers as depicted in Scheme 2. Similar
behavior is observed for amide 10 displaying N–H IR
bands at 3447 and 3336 cmÿ1 and exhibiting an inter-
mediate temperature dependence of the N–H chemical
shift (ÿ8 ppb Kÿ1) supporting a partially hydrogen-
bonded situation. Interestingly, the extent of hydrogen
bonding in amides 4 and 10 is less than in the fully
hydrogen-bonded dibenzofuran based antiparallel
amides (15-membered ring) studied previously.9,56 In
tetraamide 11, two amide–amide hydrogen bonds can
form simultaneously generating 14- and 20-membered
rings with respect to the dibenzofuran template. The
observation of only 2 amide hydrogen resonances out of
4 in the NMR spectrum suggests that the two bis-hydro-
gen-bonded diastereomers are interconverting rapidly
possibly through the non-hydrogen-bonded conformer
even at 220K (ÿ53 C) as supported by the IR bands at
Figure 2. Spectroscopic evidence for intramolecular hydrogen bond-
ing in amide 4: (a) FT-IR spectral data from the N–H stretch region of
1.5mM solution of 4 in CH2Cl2 at 25
C. The sharp band at 3446 cmÿ1
is assigned to non-hydrogen-bonded N–H, and the broad band at
3333 cmÿ1 is assigned to intramolecularly hydrogen-bonded N–H; (b)
Temperature dependence of the amide proton chemical shift of amide
4 in 1.5mM CD2Cl2 solution.
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3419 and 3323 cmÿ1. The IR and NMR data on the
simple diamides composed of 1 outlined above demon-
strates that template 1 facilitates formation of a partially
hydrogen-bonded 14-membered ring conformation.
Even though the formation of a 14-membered ring
hydrogen bond does not appear to be as favorable as the
15-membered ring hydrogen-bonded conformer formed
in amides derived from 4-(2-aminoethyl)-6-dibenzo-
furanpropionic (for antiparallel b-sheet nucleation),
template 1 still nucleates parallel b-sheet formation in
aqueous solution when flanked by hydrophobic residues.
This is most likely a result of the additional stabilization
provided by the hydrophobic interactions (vide infra).
Synthesis of symmetrical peptidomimetics incorporating
template 1
Standard solid-phase peptide synthesis was carried out
employing the p-nitrobenzoyl oxime resin.45–47,56 The
resin-bound protected peptides were cleaved from the
oxime resin by nucleophilic displacement with ammo-
nium acetate or a primary or secondary amine in the
presence of DIEA in DMF.58 The resulting N-Boc and
side-chain protected peptide was precipitated in water.
After filtration, the fragment was dried under vacuum
and characterized by MALDI MS. The Boc-N terminal
protecting group was generally removed with TFA, and
when necessary (ascertained by analytical HPLC) the
side chain protected fragments were purified by reverse
phase C18 HPLC. The side-chain protected peptide
fragments having free N-termini were then reacted with
the bis-pentafluorophenyl ester 2 in DMF. The com-
pleteness of the coupling reaction was monitored by
HPLC noting the disappearance of bis-penta-
fluorophenyl ester 2 (limiting reagent).48 The protected
peptidomimetic was side chain deprotected by catalytic
transfer hydrogenation in formic acid59,60 or using the
high HF method.61 All peptides were purified by reverse
phase HPLC and characterized by MALDI MS.62
General strategy for synthesizing asymmetrical parallel
-sheets on solid supports
Asymmetric templated parallel sheet sequences incor-
porating 1 were prepared using a new solid-phase strat-
egy outlined in Scheme 1. Briefly, one strand of the
peptidomimetic was synthesized on a low loading benz-
hydrylamine resin (BHA) using a traditional stepwise
solid phase strategy.63 The amino terminus of this resin-
bound strand was then reacted with the bis-penta-
fluorophenyl ester 2 to aord the resin-bound mono-
active ester 2A. The unprotected amino terminus of a
second soluble side chain protected peptide strand (pre-
pared on the oxime resin as described above) was used
to displace the remaining pentafluorophenol group from
the resin bound active ester 2A via a fragment con-
densation reaction aording a protected resin-bound
asymmetric parallel b-sheet peptidomimetic. The pep-
tide was side chain deprotected and cleaved from the
resin employing a high HF treatment61 purified by
reverse phase HPLC and characterized by MALDI MS.
Evaluation of 4,6-dibenzofuranbispropionic acid (1) as a
parallel -sheet nucleator
The a-amino acid sequences used to evaluate the e-
cacy of 1 as a folding nucleator generally have an
amphiphilic periodicity of 2. As such, the hydrophobic
and hydrophilic residues project from opposite sides of
the plane of the b-sheet in an eort to maximize the
intramolecular side-chain hydrophobic interactions
which stabilize the parallel b-sheet structure (Table 1).
The amino acids making up the sequences within have
high b-sheet propensities as determined by the thermo-
dynamic scales published by Regan, Kim, and
Berg.4,8,32–36 Cationic residues were incorporated in the
hydrophilic positions to facilitate solubility and mitigate
self-assembly via electrostatic repulsion. Residue 1 is
typically flanked with hydrophobic a-amino acid resi-
dues to facilitate hydrophobic cluster formation made
possible by the interaction of the dibenzofuran skeleton
with the side chains of the flanking a-amino acid resi-
dues (Fig. 1). Symmetrical peptides A, B, and C were
synthesized using the segment condensation reaction
between 2 and the side chain protected peptides whose
sequences are shown in Table 1. Far-UV CD and FT-IR
spectroscopy were employed to evaluate the extent of b-
sheet structure exhibited by each. A CD minimum at
2155nm with a mean residue ellipticity of &ÿ15,000
is characteristic of parallel b-sheet structure, whereas a
random coil structure exhibits a minimum at 198 nm.1
The FT-IR amide I0 bands in the range of 1620–
1640 cmÿ1 (sometimes below 1620 cmÿ1) are indicative
of a b-sheet conformation, whereas an disordered con-
formation usually shows absorption bands between
1640 and 1648 cmÿ1 in deuterium oxide solution.64–67
Table 1 Primary sequences of peptides A–H*
Peptide R1 R2 R3 R4 R5 R6 R7 R8 R9 R10 R11 R12 R13
A R-Leu Orn Val -1- Val Orn Leu-R
B R-Leu Val Orn -1- Orn Val Leu-R
C R0-Lys Val Lys Val Lys Val -1- Val Lys Val Lys Val Lys-R0
D R0-Lys Val Lys Val Lys Ser -1- Ser Lys Val Lys Val Lys-R0
E Lys Val Lys Val Lys Val Gly-Gly Val Lys Val Lys Val Lys-R0
F R0-Lys Val NMeLeu Val -1- NMeLeu Lys Val Lys-R0
G R0-Lys Val Lys Val NMeLeu Val -1- Val Lys NMeLeu Lys Val Lys-R0
H Val Lys NMeLeu Lys Val Lys-R0
*Sequences are written from the C-terminus to residue 1 and from residue 1 to the C-terminus. The C-terminal functional groups represented by R
and R0 correspond to the morpholine amide (C(O)morpholine) and primary amide (C(O)NH2), respectively. For peptides E and H, the sequences
are written from the N-terminus to the C-terminus. NMeLeu refers to Leu bearing a N-methyl group in place of the amide NH. For an example, see
line drawing Figure 5 corresponding to peptide A.
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Heptapeptide A (Table 1) adopts a partial b-sheet
structure in aqueous solution as discerned by the far-
UV CD minima at 214 nm and 198 nm, corresponding
to b-sheet and random coil contributions, respectively
(Fig. 3(a)). The FT-IR absorption bands at 1619 and
1640 cmÿ1 are also consistent with the existence of
b-sheet and random coil conformations, respectively.65
The CD spectra exhibited by peptide A were invariant
over the pH range of 4.0–8.0 and the peptide con-
centration range of 5 mM to 0.6mM. The analytical
equilibrium ultracentrifugation data aorded an appar-
ent molecular weight of 1052 (see supplementary mate-
rial) indicating that peptide A (MW=1102) adopts a
monomeric structure in aqueous solution under these
conditions. The random coil contributions observed in
the IR and CD spectra most likely result from structural
fraying at the C-termini, which is also observed in the
antiparallel templated heptapeptides (vide infra).9,27,44,68
The importance of hydrophobic clusters in the initial
stages of protein folding has been addressed experi-
mentally by several groups.9,29,44,69,70 The importance of
a hydrogen-bonded hydrophobic cluster in the nuclea-
tion of parallel b-sheet structure by residue 1 can be
probed spectroscopically using several of the peptides in
Table 1. The -CH2CH2- linker connecting the dibenzo-
furan ring to the peptide strands allows the template to
adopt a low energy perpendicular conformation where
the aliphatic carbon–carbon bond is oriented perpendi-
cular to the plane of the aromatic ring (Fig. 1).9 Hepta-
peptide A is an ideal system to study the hydrophobic
cluster because it is a monomeric partial b-sheet struc-
ture presumably nucleated by the hydrophobic cluster
derived from the subsequence -Val-1-Val-. The diacid
residue 1 is achiral and would not be expected to exhibit
a near-UV CD spectrum unless it is placed in a chiral
environment, e.g. by virtue of its interaction with the
side chains of the flanking chiral a-amino acid residues.
Peptide A does exhibit a near-UV CD spectrum origi-
nating from the dibenzofuran chromophore (Fig. 3(b))
consistent with its participation in hydrophobic cluster
formation. NMR studies on peptide A provide further
support for this interpretation as the g-methyl protons
of the flanking Val residues are shifted upfield as a result
of their placement in the shielding cone of the dibenzo-
furan ring system in the hydrophobic cluster conforma-
tion (Figs 4 and 1).27,28
Furthermore, NOEs observed between the g-methyl
protons in the Val residues and the H1 and H9 protons
of the dibenzofuran ring system (Fig. 5) also support the
existence of the hydrophobic cluster shown in Figure 1.
Amide H/D exchange studies on peptide A clearly indi-
cate that the amide protons of the flanking residues are
protected from exchange unlike the other amide protons
in peptide A, which exchange rapidly when dissolved in
D2O solution at pD* 3.5. Even though this symmetrical
peptide may be expected to exhibit asymmetry as a
result of its parallel hydrogen-bonding network, it exhi-
bits apparent C2 symmetry suggesting that the two dia-
stereomeric parallel b-sheet structures interconvert
rapidly, most likely through a mono-hydrogen-bonded
intermediate as suggested by the H/D exchange data
(Fig. 5) and previous studies.25 The fast exchange
between diastereomeric hydrogen bonding networks
was also observed in amides composed of 1 studied in
CH2Cl2 by NMR. Molecular dynamics/simulated
annealing studies, constrained by observed NOEs in
peptide A, suggest that the conformational preference of
residue 1 makes it possible for the hydrophobic side
chains of the flanking a-amino acid residues to interact
with the dibenzofuran skeleton, while the backbone
atoms of the flanking a-amino acid residues participate
in idealized intramolecular hydrogen bonding between
the flanking a-amino acids aording the hydrogen-bon-
ded hydrophobic cluster shown in Figure 1.
Peptide B has the same amino acid composition as
peptide A, but the sequence diers in that the hydro-
philic Orn residues now flank 1, Table 1. Peptide B does
not adopt a b-sheet structure as indicated by the far-UV
CD minimum at 198 nm consistent with an ensemble of
unordered conformations (Fig. 3(a)). Furthermore, the
near-UV CD minimum of peptide B at 282 nm is not
nearly as intense as that of peptide A, suggesting that a
hydrogen-bonded hydrophobic cluster is not as well-
defined, if formed at all (Fig. 3(b)). As a result, peptide
B does not fold into a parallel b-sheet-like structure
Figure 3. Circular dichroism spectra of 0.1mM solution of peptide
A(A) and peptide B(B) in 10mM acetate buer at pH 4.0: (a) Far-UV
CD; (b) Near-UV CD.
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Figure 4. 1D NMR spectra of the Val and Leu aliphatic side-chain regions of peptide A(A) and peptide B(B) in deuterated acetate buered H2O/
D2O (90/10) at 25
C. Note the significant upfield shift of the Val-3 and Val-5 methyl groups in peptide A relative to those in peptide B. The upfield
shift further supports the hydrophobic cluster conformation adopted by the -(Val-3)-1-(Val-5)- subsequence in peptide A.
Figure 5. Line drawing summarizing NOEs observed in peptide A (indicated by double-headed arrows) which is ordered in the vicinity of 1 and less
structured at the termini. Amide H/D exchange rates (minÿ1, 25 C) for peptide A were obtained from 4mM sample at pD* 3.5. The rate (minÿ1)
reported by the numbers at the end of the arrows pointing to the NH were averaged from three experiments. The NOE data were obtained on 1mM
sample at pD* 3.5.
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(Fig. 3(a)). The Orn residues in the flanking positions
are not able to pack suciently to form a well-defined
hydrophobic cluster, consistent with the markedly
decreased ability of the Orn and Lys side chain residues
to participate in hydrophobic cluster formation with the
dibenzofuran ring system in the case of the antiparallel
dibenzofuran-based nucleator.27,28
The hydrogen-bonded hydrophobic cluster formed by
the subsequence -hydrophobic -amino acid-1-hydro-
phobic -amino acid- should be able to form a better-
defined parallel b-sheet structure in longer a-amino
sequences as a result of an increased number of favor-
able hydrogen bonding and hydrophobic interactions
between the a-amino acid residues in the b-strands.
TridecapeptideC (Table 1), having a repeating (Val-Lys)n
sequence, was prepared to test this hypothesis. Peptides
with repeating (Val-Lys)n sequences are known to
undergo a coil to self-associated b-sheet transition
around pH 8.5.27,71,72 At pH 4, the high charge density
in the a-amino acid portion of tridecapeptide C prevents
favorable strand–strand interactions required for sheet
formation. However, the hydrophobic cluster is struc-
turally well-defined at this pH and is poised to nucleate
folding once solution conditions permit strand–strand
interactions. The characteristic near-UV CD signal, the
upfield shifted g-methyl groups of flanking Val residue,
and NOEs between the g-methyl groups of the flanking
side chains and the dibenzofuran skeleton are present at
pH 4 in peptide C (Fig. 6).
A pH dependent coil to b-sheet transition is observed by
far-UV CD and FT-IR over the pH range of 8–8.5 for
peptide C (Fig. 7), likely facilitated by neutralization of
at least two charges on the e-ammonium groups of Lys
residues in keeping with the analogous templated anti-
parallel peptide.27 The transition from coil to sheet can
also be induced by increasing the ionic strength of the
medium at pH 4 (>200mM NaCl) providing further
evidence that the hydrophobic cluster is poised and
waiting to nucleate folding at pH 4 once unfavorable
electrostatic interactions between the strands are
reduced. Upon intramolecular folding, peptide C spon-
taneously self-assembles into a high molecular weight
soluble quaternary structure, as discerned from the red
shifted minimum (216 nm) in the far-UV CD spectrum.
The ellipticity at 216 nm becomes more intense with
increasing peptide concentration consistent with self-
assembly.
Sedimentation equilibrium analysis of peptide C
(35 mM, @ pH 4 in the presence of 250mM NaCl)
showed the loss of 40% of the sample due to self-
assembly. Analysis of the material left in solution gave
an apparent molecular weight of 1690 by equilibrium
ultracentrifuge analysis compatible with the monomeric
structure of peptide C (1673). Increase of NaCl con-
centration at pH 4 further increases loss of peptide due
to self-assembly. Furthermore, complete loss of material
was observed when peptide C was studied at pH 8.5.
This peptide sediments to the bottom of the analytical
ultracentrifugation cell implying that peptide C is asso-
ciated into a high molecular weight quaternary structure
and certainly not monomeric. A structural evaluation of
the soluble but associated form of peptide C was
undertaken by exposing a carbon coated electron
microscopy grid to the aqueous solution of peptide C
(50 mM) at pH 4 in the presence of 250mM NaCl. The
resulting electron micrographs reveal a cross-b structure
where the individual b-strands appear to be oriented
perpendicular to the long axis of the fibril based on
morphology and dimensions.
Infrared evidence suggests that the observed self-assem-
bly is mediated by an intermolecular parallel b-sheet
interaction. This is expected because it is energetically
unfavorable to have a single strand participating in both
parallel and antiparallel b-sheet hydrogen bonding, as
parallel sheets typically exhibit more pronounced pleat-
ing than antiparallel sheets.1,5 It has been noted pre-
viously that the amide I0 FT-IR absorption band of an
associated parallel b-sheet is observed at higher fre-
quency when compared to that of an associated anti-
parallel b-sheet.73,74 A comparison of the FT-IR of films
generated from peptide C in water to films produced
from the homologous antiparallel b-sheet sequence
((K-V)3-4-(2-aminoethyl)-6-dibenzofuranpropionic acid
residue-(V-K)3-NH2) in water shows that peptide C
exhibits a strong absorption band at 1630 cmÿ1, at
higher energy than the corresponding antiparallel band
at 1626 cmÿ1. The antiparallel 1626 cmÿ1 band is
accompanied by a weak band at 1690 cmÿ1, the latter
band being weak or absent in the apparent parallel b-
sheet film of peptide C (Fig. 8).
Peptide D was prepared to further probe the importance
of hydrophobic cluster formation involving the sub-
sequence -Val-1-Val- in the folding of the parallel tri-
decapeptide C. Peptide D is homologous to peptide C
except for the incorporation of Ser residues in place of
the flanking Val residues. Ser was chosen because it has
a high b-sheet propensity, but is not expected to stabi-
lize hydrophobic cluster formation owing to its hydro-
philic nature.32,34 The Far-UV CD spectrum of peptide
D at pH 8.5 exhibits a minimum at 198 nm and a FT-IR
amide I0 band at 1640 cmÿ1 consistent with a rapidly
interconverting ensemble of conformations (Fig. 9). The
absence of a notable near-UV CD spectrum suggests
that the hydrophobic cluster critical for the folding of
peptide D is poorly defined, if defined at all. The
inability of peptide D to undergo b-sheet folding at pH
8.5 appears to result from its incapability to form a
hydrogen-bonded hydrophobic cluster, which appears
to be critical for b-sheet nucleation.
Peptide E has the same amphiphilic a-amino acid
sequence as that of peptide C, except that the nucleator
1 is replaced with the dipeptide sequence Gly-Gly.
Replacement of 1 with the dipeptide Gly-Gly allows this
portion of peptide E the flexibility to sample a number
of possible conformations, including a reverse turn
conformation, and to fold into a b-sheet structure if the
K-V based a-amino acid sequence has a propensity to
do so. Peptide E is not competent to fold into a b-sheet
structure at pH 8.5, where peptide C exhibits the coil to
sheet transition. Peptide E adopts an ensemble of
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Figure 6. (a) Near-UV CD spectrum of 0.1mM solution of peptide C(C) at pH 4.0 (25 C). (b) 1D NMR spectra of the Val aliphatic side-chain
region of peptide C in deuterated acetate buered H2O/D2O (90/10) (pD* 4.0) at 25
C. Note the significant upfield shift of the Val-6 and Val-8 g-
methyl groups in peptide C relative to those in the other positions. The upfield shift further supports the hydrophobic cluster conformation adopted
by the -(Val-6)-1-(Val-8)- fragment of peptide C. (c) Aromatic to aliphatic region of the ROESY spectrum of peptide C in acetate buer pH 4.0 at
25 C showing the NOE’s between the aromatic ring of the Dibenzofuran residue and the g-protons of the Val-6 and Val-8 in boxes.
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unordered conformations over the pH range of 4 to 8.5
as discerned by the far-UV CD minimum at 198 nm
and the FT-IR amide I0 band exhibited at 1640 cmÿ1,
suggesting that both the nucleator 1 and the hydrogen-
bonded hydrophobic cluster are required for b-sheet
formation in peptide C.
Since intramolecular folding and b-sheet mediated self-
assembly are linked in the case of peptide C, it is di-
cult to prove that folding proceeds self assembly and
hence that parallel b-sheet nucleator 1 is functional.
Therefore, peptides incorporating 1 which are capable
of folding but incapable of subsequent self-assembly are
desirable for evaluating the nucleating ability of 1. Sev-
eral research groups have successfully used N-methy-
lated a-amino acids in the exterior b-strands at sites not
involved in intramolecular hydrogen bonding as a
means of preventing self-assembly of folded antiparallel
b-sheet structures.42–44 The N-methylated residues are
incapable of serving as a hydrogen bond donor and
sterically prevent close approach of two strands. We
have prepared two N-methylated peptides composed of
1 which should adopt an intramolecular parallel b-sheet
structure, but are incapable of self-assembly (inter-
molecular parallel b-sheet formation).
The asymmetrical N-methylated nonpeptide F and tri-
decapeptide G were synthesized according to the
method outlined in Scheme 1 to uncouple folding and
self-assembly. Peptide F exhibits a far-UV CD minima
at 215 nm in acetate buer at pH 4 and a red shifted
minima in isopropyl alcohol and TFE (224 nm) with a
crossover to positive ellipticity at 193 nm in TFE
(Fig. 10(a)). The amide I0 bands of peptide F at 1630
and 1640 cmÿ1 in deuterium oxide (pD* 3.5) are sup-
portive of a structure having both parallel b-sheet and
random coil components, respectively. A 50 mM solu-
tion of Peptide F is monomeric at pH 4 in acetate buer
at 25 C according to the analytical equilibrium ultra-
centrifugation data which yields an apparent molecular
weight of 1253, agreeing remarkably well with the
expected molecular weight of 1246 for monomeric pep-
tide F (Fig. 11). As expected the near-UV CD signal is
most intense in aqueous buer at pH 4 and less intense
in TFE and isopropanol solvents, consistent with our
expectation that TFE and IPA would disrupt the
hydrophobic cluster by hydrophobic competition
(Fig. 10(b)). In spite of the disordered hydrophobic
cluster in alcohol solvents, the parallel b-sheet structure
appears to be more pronounced by far-UV CD analysis,
probably due to the increased importance of intramole-
cular hydrogen bonding by lowering the dielectric con-
stant around the amide bonds.75,76 The temperature
dependent far- and near-UV CD spectra of peptide F
are very interesting. The hydrophobic cluster is best
defined at 1 C as discerned from the intensity of the
minimum at 282 nm. The minimum at 282 nm becomes
less intense linearly with increasing temperature up to
50 C, as a probable result of thermal motion and then
decreases markedly after that (Fig. 12(b)). The tem-
perature-dependent ellipticity at 224 nm is linear and
becomes more intense with increasing temperature from
1 C to 80 C (Fig. 12(a)). The minimum in the far-UV
CD spectrum of Peptide F broadens and red shifts with
increasing temperature. Importantly, peptide F appears
to be quite stable at physiological temperature, perhaps
Figure 7. (a) Far-UV CD spectra of 0.10mM solution of peptide C as
a function of pH. (b) Amide I0 FT-IR analysis of 7mM solution of
peptide C in deuterium oxide at pD* 3.5 and pD* 8.5.
Figure 8. Comparison of the FT-IR amide I region of films of parallel
peptide C and the analogous antiparallel sequence. The parallel b-
sheet peptide C exhibits a strong absorption band at 1630 cmÿ1
whereas the antiparallel b-sheet peptide analogous to C (see text)
shows a strong band at 1626 cmÿ1 accompanied with a weak band at
1690 cmÿ1.
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as a result of the temperature dependence of the hydro-
phobic eect and appears to be less structured at low
temperature, perhaps due to a partial cold denaturation
phenomenon (Fig. 12). However, it has proven dicult
to denature this peptide at either extreme of tempera-
ture. This is most likely owing to the fact that the
nucleator is always in the ‘ON’ position which makes
equilibrium unfolding nearly impossible due to the
likely rapid rate of folding.
The sequence specific 1H NMR assignments in peptide
F have been made by a combination of TOCSY,
ROESY and related NMR methods.77 The N-methyl-
ated amino acid residues in peptide F appear to
exclusively adopt the trans conformation which facil-
itates parallel b-sheet hydrogen bonding and favorable
side chain–side chain interactions. Intramolecular sheet
formation probably selects the trans-isomer which likely
explains why none of the cis-isomer is observed by
NMR. The characteristic NOEs for the hydrogen-bon-
ded hydrophobic cluster were observed between the
aromatic protons of residue 1 and the flanking Val
and N-methyl-Leu residues, (Fig. 13). Amide H/D
exchange experiments provide strong evidence for a
parallel b-sheet-like hydrogen-bonding network in
peptide F, (Fig. 13). The amide NHs that should be
involved in hydrogen bonding and thus protected from
rapid exchange exhibit an order of magnitude slower
exchange at pD* 3.3 relative to the terminal residues
and the disordered residues of the analogous alternating
sequence in Peptide A (Fig. 5). The H/D exchange stu-
dies also support the interpretation that the random
contributions in the CD and IR spectra result in large
part from structural fraying at the termini. The fastest
H/D exchange rates are observed for the terminal resi-
dues in keeping with their minimal participation in
intramolecular hydrogen bonding. Unfortunately,
strong interstrand NOEs in peptide F, characteristic of
well-defined parallel b-sheet structure are not observed,
suggesting that the structure of peptide F is much more
dynamic than a parallel b-sheet structure in a protein.
Tridecapeptide G has its N-methylated a-amino acid
residues positioned further away from the nucleator to
evaluate the role of the placement of these residues in
achieving intramolecular folding and preventing self-
assembly. Peptide G exhibits a pH independent far-
UV CD minima at 198 and 215 nm, consistent with
increased contributions from random coil and what
Figure 10. CD spectra of 0.1mM solution of peptide F in 10mM
acetate buer (at pH 4.0), trifluroethanol, and isopropanol: (a) Far-
UV CD; (b) Near-UV CD.
Figure 9. (a) Far-UV CD study of 0.10mM solution of peptide D as a
function of pH. (b) Amide I0 FT-IR analysis of 7mM solution of
peptide D in deuterium oxide at pD* 7.0: the original (- - -), and fourier
self deconvoluted (—) FT-IR spectra.
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appears to be a decrease in the extent of b-sheet struc-
ture relative to peptide F, (Fig. 14). The FT-IR amide
I0 bands exhibited by peptide G at 1631 and 1640 cmÿ1
in deuterium oxide (pD* 3.8) also support a structure
consistent with b-sheet and random coil contributions,
respectively. Peptide G (50 mM) adopts a monomeric
structure at pH 4 as discerned from the analytical equi-
librium ultracentrifugation data collected at 40 C. The
observed molecular weight (1850) is consistent with
expected molecular weight of the monomer (1701). The
temperature-dependent changes in the far- and near-UV
CD spectra of peptide G imply a gradual increase in b-
sheet structure and a more disordered hydrophobic
cluster as the temperature is increased from 1 C to
80 C. The minimum in the far-UV CD spectrum
broadens and red shifts to 224 nm with increasing tem-
perature concomitant with a decrease in intensity of the
random coil CD minimum. The temperature dependent
transitions were reversible upon heating, however these
transitions do not appear to be cooperative, consistent
with the preorganized nucleus and small noncooperative
poorly defined sheet structure. The interpretation that
the random coil signal in both the CD and IR spectra
largely results from the peptides strands fraying at the ends
is strongly supported by the H/D exchange experiments.
The sequence specific assignments of the 1Hs in peptide
G, making the H/D exchange experiments possible
(Fig. 15), were carried out by a combination of TOCSY
and ROESY NMR methods.77 The observable inter-
mediate range NOEs supporting the hydrogen-bonded
hydrophobic cluster structure are depicted in Figure
15. The NMR data demonstrate that both of the N-
methylated Leu residues in peptide G adopt the trans
conformation compatible with parallel b-sheet forma-
tion. None of the cis-isomer was detected by NMR. The
fact that characteristic interstrand NOEs for well-
defined parallel b-sheet structure were not observed in
peptide G indicate that the b-sheet-like structure of
peptide G is more dynamic than that seen in a protein,
as supported by the amide H/D exchange data. The
amide exchange rates (minÿ1, Fig. 15) observed for each
residue in peptide G are about the same except for the
terminal Lys residues, which exchange very rapidly,
suggesting that the interconversion of peptide G among
the diastereomeric H-bonding networks is much faster
than the NMR time scale.
A red shifted minima is observed in the CD spectra of
peptide G when dissolved in mixtures of TFE and water
(up to 224 nm in 40% TFE). As the fraction of TFE in
the solvent increases so does the b-sheet ellipticity at the
expense of random coil signal (Fig. 16), similar to what
was observed with peptide F. The near-UV CD signal
intensities at 282 nm do not change significantly as TFE
is added up to 40%. Increasing the fraction of TFE to
100% results in unchanged far-UV and near-UV CD
signal for hydrophobic cluster compared with that
observed at 40% TFE in aqueous solution. This is
Figure 11. (a) Analytical ultracentrifugation sedimentation equili-
brium of a 50mM solution of peptide F in 10mM acetate buer (pH
4.0) at 60,000 rpm. The solid line drawn through the data was obtained
by fitting the absorbance versus radial position r to an equation of a
single-ideal species model. (b) The residual dierence between the
experimental data and fitted data for each point.
Figure 12. Temperature-dependent CD spectra of 0.1mM solution of
peptide F in 10mM acetate buer at pH 4.0: (a) Far-UV CD, (b)
Near-UV CD.
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somewhat surprising, the interpretation of these results
is unclear at the moment.
Interestingly, the near-UV CD band of peptide G in
pure isopropanol is not detectable, however the far-UV
CD exhibits an intense minimum at 223 nm along with a
weak negative band at 198 nm consistent with a b-sheet
and random coil conformations, respectively. The
intense FT-IR amide I band of peptide G in IPA at
1636 cmÿ1 further supports an increase in b-sheet struc-
ture in this solvent (Fig. 17).78 Significantly, the b-sheet
structure observed in isopropanol is much more sensi-
tive to change in temperature exhibiting denaturation
above 45 C with a marked increase in random coil
structure. This is expected considering that hydrogen
bonding is likely to be the principal stabilizing force in
neat isopropanol (no hydrophobic cluster).
Peptide H was synthesized as a far-UV CD and FT-IR
spectral standard for a largely unordered peptide con-
taining an N-methylated a-amino acid residue. Pep-
tide H was designed to have the same amino acid
composition as one of the strands in peptide G. Peptide
H exhibits a strong random coil signal at 198 nm with a
mean residue ellipticity approaching ÿ10,000 and a
much weaker minimum at 225 nm having a mean resi-
due ellipticity approaching ÿ4000. The FT-IR band at
1640 cmÿ1 observed for peptide H is also supportive of a
rapidly interconverting ensemble of conformations and
lacks a signal for b-sheet structure. This data is con-
sistent with the observation from analytical ultra-
centrifugation that this peptide is monomeric. The
temperature-dependent far-UV CD data on peptide H is
interesting in that the signal at 223 nm increases with
temperature without a concomitant change in the ran-
dom coil signal at 198 nm. The fact that the temperature
dependent change in far-UV CD occurs at 225 nm, but
not at 198 nm suggests that the N-methylated amino
acid is contributing to an apparent increase in b-sheet
structure at higher temperature. However, it is clear that
this is the wrong interpretation because the random coil
signal is not decreasing with increasing temperature and
the FT-IR spectrum clearly supports a random coil
structure. Care must be exercised when interpreting
temperature dependent far-UV CD data on peptides
composed of one or more N-methylated a-amino acids.
A temperature dependent increase in b-sheet structure
by circular dichroism must be supported by a decrease
in random coil structure, and preferably by an indepen-
dent spectroscopic method such as FT-IR, as in the case
of peptides F and G.
Conclusions
The aromatic diacid residue 4,6-dibenzofuranbis-
propionic acid (1) nucleates a parallel b-sheet-like
structure in small peptides in aqueous solution via a
hydrogen-bonded hydrophobic cluster. The majority of
the parallel b-sheet structures evaluated undergo linked
intramolecular folding and self-assembly, aording a
fibrillar b-sheet quaternary structure. Strategically
located N-methylated a-amino acid residues in the
sequences prevent self-assembly. It is likely that the uti-
lization of sophisticated computer programs for the
design of strand–strand packing will be necessary to
achieve uniquely folded two-state parallel b-sheet struc-
tures incorporating 1.
Figure 13. Summary of observed NOEs for peptide F (indicated by double-headed arrows) which is ordered in the vicinity of 1 and less structured at
the termini. Amide H/D exchange rates (minÿ1, 25 C) for peptide F were obtained from 1.54mM sample at pD* 3.3. The rate (minÿ1) reported by
the numbers at the end of the arrows pointing to the NHs were averaged from three experiments. The NOE data were obtained on 1.54mM sample
at pD* 4.
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Experimental
General methods and material
The dibenzofuran used in these studies was purchased
from Aldrich or from Lancaster. Anhydrous N,N-
dimethylformamide (DMF), thionyl chloride, and
N,N0-dicyclohexylcarbodiimide (DCC) were obtained
from Aldrich. Dichloromethane (CH2Cl2) was obtained
from EM Science and distilled from calcium hydride.
Triethylamine (TEA) was refluxed over ninhydrin, dis-
tilled, and distilled again from calcium hydride. Benzy-
lamine, isobutylamine, and piperidine were purchased
from Aldrich and distilled from KOH prior to use. The
Bop reagent ((Benzotriazol-1-yloxy)tris-(dimethylami-
no)phosphonium hexafluorophosphate) was purchased
from Chem-Impex International and was handled in a
fume hood. The hexamethylphosphoric triamide
(HMPA) (CAUTION! Known carcinogen) resulting
from coupling with Bop reagent was removed by
extraction with 1 M HCl or 5% acetic acid (HOAc) in
water. Pentafluorophenol (PCR Fluoroorganics), Boc-
valine (Advance Chemtech), l-valine methyl ester
hydrochloride (Aldrich) and other reagents were reagent
grade and used without further purification. Tri-
fluoroethanol (TFE) (Aldrich) was NMR grade,
+99.5% and used without purification. Isopropanol
(EM Science) for CD and IR studies was reagent grade
and distilled over calcium hydride prior to use. Melting
points were determined using a mel-temp apparatus and
are uncorrected. Routine NMR spectra were acquired
on a Varian XL-200E. Variable-temperature NMR
experiments were performed on a Varian XL-400 or
Unity Plus 300 spectrometer. FT-IR data were collected
on an ATI-Mattson Galaxy Series 5000 or 6021 spec-
trometer equipped with a MCT detector using a CaF2
solution cells having a 3mm and 0.015mm path length.
Mass determinations were carried out on a VG-70S
double focusing high-resolution mass spectrometer. A
Figure 14. (a) Far-UV CD study of 0.10mM solution of peptide G as
a function of pH. (b) Amide I0 FT-IR analysis of 7mM solution of
peptide G in deuterium oxide at pD* 3.8: the original (- - -), and fourier
self deconvoluted (—–) FT-IR spectra.
Figure 15. Summary of observed NOEs for peptide G (indicated by double-headed arrows) which is ordered in the vicinity of 1 and less structured at
the termini. Amide H/D exchange rates (minÿ1, 25 C) for peptide G were obtained from 4.0mM sample at pD* 3.0. The rate (minÿ1) reported by
the numbers at the end of the arrows pointing to the NHs were averaged from three experiments. The NOE data were obtained on 4.23mM sample
at pD* 4.
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matrix assisted laser desorption ionization (MALDI)
mass spectrometer constructed by Dave Russell and co-
workers at Texas A&M University was used to obtain
nominal masses of peptides prepared within to confirm
their primary structure. Preparative HPLC was carried
out on a Waters2 600E Multisolvent Delivery System.
The column employed was a Waters RCM Delta Pak
C18 (15 mm, 300 A˚, 25100mm) attached to a Knauer
86 variable-wavelength detector set at 254 nm. Solvent
A was composed of 95% water, 5% acetonitrile (EM
Science, HPLC grade), with 0.2% TFA added. Solvent
B was composed of 5% water, 95% acetonitrile, 0.2%
TFA. Far- and near-UV circular dichroism (CD) spec-
tra were performed on AVIV 62A DS spectrometer
equipped with Igor software and reported in units of
mean residue ellipticity.79 Aqueous 1D and 2D NMR
spectra were recorded on a Varian 500 Unity Plus spec-
trometer in deuterated acetate buered H2O/D2O (90/
10) at 25 C. The ethyl acetate (EtOAc) used for flash
chromatography was ACS reagent grade.
Synthesis of 4,6-dibenzofuranbispropionic acid (1). The
synthesis of the starting material, 4,6-dibenzofuran-
bispropionic acid, 1, was performed as described by
Tsang et al.9
Synthesis of the bis-pentafluorophenyl ester 2. A 25-mL
round-bottomed flask was charged with 1 (0.62 g,
2mmol), pentafluorophenol (0.75 g, 4.1mmol), and
15mL of ethylacetate/DMF mixture (2.6/1 ratio). The
solution was stirred under N2 at 0
C, and N,N0-dicy-
clohexylcarbodiimide (0.93 g, 4.5mmol) was added as a
solid. The reaction was stirred at 0 C for an additional
1 h and then allowed to warm to room temperature with
stirring for an additional 3–5 h. The conversion of 1 to
the bis-pentafluorophenyl ester was monitored by TLC
using a hexane/EtOAc/HOAc (70/29/1) solvent system.
After completion, the reaction mixture was cooled to
0 C for 30min (without stirring) and filtered to remove
the N,N0-dicyclohexylurea (DCU) precipitate, which
was washed three times with EtOAc (10mL). The reac-
tion filtrate and EtOAc washings were combined and
concentrated to yield a white solid. The solid was redis-
solved in EtOAc which was cooled (0 C) for 1 h to
precipitate the remaining DCU. The solution remaining
after filtration was concentrated to yield a white solid
which was recrystallized from a hexane/EtOAc (6/1)
solution to aord 1.03 g (1.60mmol, 80%) of 4,6-
dibenzofuran bis-pentafluorophenylpropionate 2: mp
123–124 C; 1H NMR (CDCl3, 200MHz) d 7.85 (m, 2H,
Ar-1, 9 H), 7.31 (m, 4H, Ar-2,3,7,8 H), 3.47 (t, J=8Hz,
1H, ArCH2CH2), 3.22 (t, J=7.3Hz, 1H, ArCH2CH2);
13C NMR (CDCl3) d 168.72, 154.30, 127.21, 124.34,
123.16, 119.46, 33.19, 30.91, 25.22; MS (FAB, 3-nitro-
benzylalcohol (NBA) matrix) m/z (M+) calcd for
C30H14O5F10, 644.0681, obsd 644.0679.
Synthesis of diamide 3. A 50-mL round-bottomed flask
was charged with 1 g (2.17mmol) of 2 in 35mL of
CH2Cl2. The solution was cooled to 0
C and freshly
distilled benzylamine (2.84mL, 26mmol) and TEA
(0.88mL, 6.51mmol) were added slowly under N2. The
reaction was monitored by TLC using a EtOAc/hexane/
HOAc (75/24/1) mixture as the mobile phase. The reac-
tion was stirred at room temperature for 3 h and filtered
to yield 0.82 g of crude diamide 3 as a white solid. The
filtrate was washed with 1 M citric acid (220mL), 5%
K2CO3 (220mL), water (220mL), dried (MgSO4)
Figure 16. CD spectra of 0.1mM solution of peptide G upon adding
0, 10, 40, and 70% TFE in buer pH 4 solution: (a) Far-UV CD, (b)
Near-UV CD.
Figure 17. FT-IR amide I region of 5mM solution of peptide G in
pure isopropanol: the original (- - -), and fourier self deconvoluted
(—–) FT-IR spectra.
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and concentrated to aord 0.3 g of crude diamide 3 as
a white solid. The combined crude was crystallized
from a 2/1 solution of CH2Cl2/hexane to yield 0.84 g
(1.71mmol, 80%) of diamide 3: mp 225–226 C; 1H
NMR (DMSO-d6, 200MHz) d 8.40 (t, 1H, N-H), 7.95
(m, 1H, Ar-1 H), 7.31 (m, 2H, Ar-2, 3 H and 5H, Benzyl
Hs), 4.23 (d, J=3.60Hz, 2H, -NHCH2-), 3.24 (t, 2H,
-ArCH2CH2-), 2.68 (t, 2H, -ArCH2CH2-); MS (FAB,
NBA matrix) m/z (MH+) calcd for C32H30N2O3,
491.2335, obsd 491.2339.
Synthesis of diamide 4. The starting material 5 was syn-
thesized as described by Tsang et al.9 A 100-mL round-
bottomed flask was charged with monoethylester
monoacid 5 (2.5 g, 7.3mmol) in 45mL of CH2Cl2.
Thionyl chloride (SOCl2) was added and the mixture
was heated at reflux for 30min. After the solvent was
removed under reduced pressure, the resulting oil (crude
6) was dried under vacuum for 4 h and redissolved in
40mL CH2Cl2. Isobutylamine (2.74 g, 37.5mmol) was
then added to the reaction mixture precooled to 0 C.
The reaction was stirred at 0 C for additional 10min,
and allowed to warm to room temperature. After stir-
ring at room temperature for 12 h, the reaction was
transferred to a separatory funnel, washed with 1M
citric acid (325mL), 5% NaHCO3 (325mL), dried
(MgSO4), and concentrated to yield 1.08 g (2.73mmol,
37%) of a pale-yellow oil of monoisobutylamide mono-
ethylester 7: IR (1.5mM in CH2Cl2, cm
ÿ1) 3448, 3398,
1728, 1670, 1520; 1H NMR (CDCl3, 200MHz) d 7.79
(m, 1H, Ar-1, 9 H), 7.27 (m, 2H, Ar-2,3,7,8 H), 5.83 (s,
1H, NH), 4.09 (q, J=7.1Hz, 4H, ÿOCH2CH3), 3.33 (t,
J=7.8Hz, 2H, ArCH2CH2), 3.02 (t, J=6.8Hz, 2H,
ÿNCH2CH), 2.84 (t, J=7.6Hz, 2H, ArCH2CH2), 2.73
(t, J=7.3Hz, 2H, ArCH2CH2), 1.65 (m, J=8.0Hz, 1H,
ÿCH(CH3)2), 1.17 (t, J=7.1Hz, 3H, ÿCH2CH3), 0.78
(d, J=6.7Hz, 6H, ÿCH(CH3)2). MS (FAB, NBA
matrix) m/z (M+) calcd for C24H29NO4, 395.2096, obsd
395.2050.
A 15-mL round-bottomed flask was charged with 7
(0.5 g, 1.26mmol), NaOH (0.08 g, 1.89mmol) and 5mL
of EtOH, and the solution was heated at reflux for 2 h.
After the solvent was removed under reduced pressure,
the crude product was dissolved in 25mL of water and
the solution was acidified using 1M HCl. The suspen-
sion was extracted into CH2Cl2 (340mL), dried
(MgSO4), and concentrated to aord 0.47 g (100%)
of monoisobutylamide monoacid 8. This compound
was used in the synthesis of 4 and 10 without further
purification.
A 50-mL round-bottomed flask was charged with 8
(0.13 g, 0.35mmol), Bop reagent (0.18 g, 0.42mmol) and
30mL of DMF. The distilled piperidine (0.69mL,
7mmol) was added to the reaction precooled to 0 C
and the reaction was allowed to warm to room tem-
perature. After stirring for 1 h, the mixture was diluted
with CHCl3 (10mL), washed with 1 M HCl (325mL),
water (325mL), dried (MgSO4), and concentrated to
aord a pale-yellow oil. The crude was dissolved in
3mL of DMF and purified by preparative C18 HPLC
using a gradient from 50–70% over 20min to yield
0.09 g (59%) white solid of diamide 4. 1H NMR
(CDCl3, 200MHz) d 7.70 (m, 2H, Ar-1, 9 H), 7.20 (m,
4H, Ar-2,3,7,8 H), 6.52 (t, 1H, N-H), 3.45 (t, 2H,
-NHCH2CH-), 3.25 (m, 6H, ArCH2CH2-, -N(CH2)-),
2.85 (t, 2H, ArCH2CH2-), 2.78 (m, 4H, ArCH2CH2-),
1.65 (m, 1H, -NHCH2CH-), 1.45 (m, 2H, -N(CH2CH2)2
CH2), 1.35 (m, 4H, -N(CH2CH2)2CH2) 0.78 (d, 6H,
-CH(CH3)2);
13C NMR (CDCl3) d 172.32, 170.43,
154.38, 154.33, 127.36, 127.06, 125.05, 124.86, 124.12,
124.02, 122.80, 118.71, 46.83, 42.65, 36.35, 33.79, 28.35,
27.07, 26.25, 25.43, 24.30, 20.01; MS (FAB, NBA
matrix) m/z (MH+) calcd for C27H34N2O3, 435.2648,
obsd 434.2650.
Synthesis of diamide 10. The synthesis of diamide 10
was performed as in the synthesis of diamide 4 except
that diethylamine (0.40 g, 5.38mmol) was used instead
of piperidine. After stirring for 15min at room tempera-
ture, the mixture was diluted with CH2Cl2 (10mL),
washed with 1M citric acid (325mL), water (325mL),
5% NaHCO3 (225mL), dried (MgSO4), and con-
centrated to aord a pale pink oil. The crude was flash
chromatographed using a 95/4.5/0.5 solution of CHCl3/
MeOH/HOAc to aord 0.07 g (49%) of diamide 10: 1H
NMR (CDCl3, 200MHz) d 7.79 (m, 2H, Ar-1, 9 H),
7.27 (m, 4H, Ar-2,3,7,8 H), 6.41 (s, 1H, NH), 3.32 (m,
8H, -CH2CH3, ArCH2CH2), 3.04 (t, J=6.2Hz, 2H,
-NCH2CH-), 2.80 (t, J=8.2Hz, 2H, ArCH2CH2), 2.78
(t, J=8.5Hz, 2H, ArCH2CH2), 1.69 (m, J=6.2Hz, 1H,
-CH(CH3)2), 1.09 (t, J=7.1Hz, 3H, -CH2CH3), 1.03 (t,
J=7.1Hz, 3H, -CH2CH3), 0.80 (d, J=6.7Hz, 6H,
-CH(CH3)2); MS (FAB, NBA matrix) m/z (M
+) calcd
for C26H34N2O3, 422.2569, obsd 422.2565.
Synthesis of diamide 11. A 25-mL round-bottomed flask
was charged with the diacid 1 (0.62mmol, 2mmol) in
10mL CH2Cl2. Thionyl chloride (4.8 g, 40mmol) was
added and the mixture was heated to reflux for 1 h.
After the solvent was removed under reduced pressure,
the resulting oil (bis-acid chloride) was dried under
vacuum for 4 h and redissolved in 10mL CHCl3.
Dipeptide H-Val-Val-OMe (5mmol) in 5mL CHCl3
and TEA (0.61 g, 6mmol) were then added to the reac-
tion at 0 C. The reaction was stirred at 0 C for an
additional 15min, and allowed to warm to room
temperature. After stirring at room temperature for 2 h,
the reaction was transferred to a separatory funnel,
washed with 1M citric acid (340mL), water
(140mL), saturated NaHCO3 (140mL), dried
(MgSO4) and concentrated to yield 1.38 g of a white
solid. The crude was recrystallized from a THF/MeOH
mixture (25/1 ratio) to aord 0.42 g (29%) of diamide
11: IR (1.5mM in CH2Cl2, cm
ÿ1) 3419, 3323, 1741,
1660, 1514; 1H NMR (CDCl3, 200MHz) d 7.74 (dd,
J=5.3Hz, 1.8Hz, 2H, Ar-1, 9 H), 7.22 (m, 4H, Ar-
2,3,7,8 H), 7.00 (t, J=10.1Hz, 4H, NH), 4.38 (dd,
J=8.5Hz, 5.3Hz, 2H, aCH), 4.21 (t, J=8.6Hz, 2H,
aCH), 3.66 (s, 6H, -OCH3), 3.32 (m, J=7.7Hz, 4H,
ArCH2CH2), 2.93 (m, J=7.0Hz, 2H, ArCH2CH2), 2.81
(m, J=7.3Hz, 2H, ArCH2CH2), 2.08 (m, J=5.8Hz,
2H, -CH(CH3)2), 1.86 (m, J=7.8Hz, 2H, -CH(CH3)2),
0.86 (d, J=6.7Hz, 12H, -CH(CH3)2), 0.76 (d, J=6.7Hz,
6H, -CH(CH3)2), 0.52 (d, J=6.7Hz, 6H, -CH(CH3)2);
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MS (FAB, NBA matrix) m/z (M+) calcd for C40H56
N4O9, 736.4047, obsd 736.4079.
Synthesis of dipeptide H-Val-Val-OMe. A 50-mL
round-bottomed flask was charged with Boc-valine
(1.1 g, 5mmol), Bop reagent (2.4 g, 5.5mmol), l-valine
methyl ester hydrochloride (1.0 g, 6mmol), and 25mL
CH2Cl2. TEA (2.0 g, 20mmol) was slowly added to the
reaction at 0 C. The reaction was stirred at 0 C for
additional 15min, and then allowed to warm to room
temperature. After stirring at room temperature for
12 h, the reaction was transferred to a separatory fun-
nel, diluted with 25mL CH2Cl2, washed with 1M citric
acid (325mL), 5% NaHCO3 (325mL), dried
(MgSO4), and concentrated. In order to remove
HMPA, the crude was redissolved in 50mL ether,
washed with 5% HOAc (530mL), dried (MgSO4), and
concentrated to aord 1.61 g (97%) of a pale-yellow oil.
The crude Boc-peptide was treated with 100mL of 25%
TFA in CH2Cl2 for 30min. The solvent was then
removed under reduced pressure to aord a crude oil
which was dissolved in 50mL CH2Cl2, cooled and neu-
tralized using dry amberlyst A-21 (10 g, 5mequiv ter-
tiary amine gÿ1 for 15min). The free amino terminal
group of a portion of the dipeptide was then converted
to an acetamide group for characterization. The free
amino terminal peptide was acetylated using acetic
anhydride (2mL) and TEA (1mL) in CH2Cl2 for 5 h.
The mixture was diluted with 25mL CH2Cl2, washed
with 1M citric acid (325mL), 5% KHCO3 (325mL),
dried (MgSO4), and concentrated to aord 0.72 g of a
pale-yellow oil. The crude was crystallized from hexane/
EtOAc mixture to aord 0.44 g (31%) of dipeptide as a
white powder: IR (1.5mM in CH2Cl2, cm
ÿ1) 3425,
1740, 1673, 1502; 1H NMR (CDCl3, 200MHz) d 6.59
(d, J=8.2Hz, 1H, NH), 6.29 (d, J=8.5Hz, 1H, NH),
4.50 (dd, J=8.0Hz, 5.0Hz, 1H, aCH), 4.36 (dd,
J=8.0Hz, 7.0Hz, 1H, aCH), 3.73 (s, 3H, OCH3), 2.10
(m, 2H, CH(CH3)2), 2.00 (s, 3H, CH3CO), 0.92 (m,
12H, CH(CH3)2); MS m/z (M
+) calcd 272.1736, obsd
272.1731.
Synthesis of peptides. Manual solid-phase peptide
synthesis was carried out by traditional solid phase
methods employing either the p-nitrobenzoyl oxime
resin or benzhydrylamine (BHA) resin as specified. The
BHA resin was purchased from Advanced Chemtech
containing an original loading of 0.98mequiv gÿ1. While
the oxime resin having a loading of 0.56mequiv gÿ1 was
prepared by following the procedure as described by
Kaiser.45 The dichloromethane (CH2Cl2), isopropyl
alcohol (IPA) and dimethylformamide (DMF) used in
peptide synthesis were reagent grade. DMF was stored
over 4 A˚ molecular sieves to reduce the primary and
secondary amine impurities. Side-chain protected Boc-
amino acids were purchased from Advanced Chemtech.
Diisopropylcarbodiimide (DIC), and thioanisole were
purchased from Aldrich and used without further pur-
ification. Bop reagent was purchased from Chem-Impex
International. Trifluoroacetic acid (TFA) was pur-
chased from Solvay Performance Chemicals and was
used as a 35% solution in CH2Cl2 containing 1%
thioanisole as a scavenger. Diisopropylethylamine
(DIEA) was purchased from Aldrich and purified
before use. DIEA was refluxed over ninhydrin, distilled,
and distilled again from calcium hydride under N2. All
peptides were purified by preparative HPLC as descri-
bed earlier and confirmed by MALDI MS.
General procedure for the synthesis of protected peptide
fragments on oxime resin. Standard solid-phase peptide
synthesis was carried out employing the p-nitrobenzoyl
oxime resin synthesized as described elsewhere.45–47,58
The resin having a loading of ca 0.5mmol gÿ1 was placed
in a reaction vessel and washed and solvated with
CH2Cl2 (15mL g
ÿ1 resin). The first amino acid was
attached to the resin by shaking 1.6 equiv of Boc-amino
acid and 1.6 equiv of DIC in CH2Cl2 containing 10%
DMF for 12–24 h. Trimethylacetic anhydride (10 equiv
in CH2Cl2) was added to cap unreacted oxime groups
on the resin. The mixture was shaken for 6–12 h at room
temperature.
The remaining amino acids were attached to the resin
bound peptide by the following procedure: (1) wash
resin with DMF (21min), CH2Cl2/IPA (3/1 ratio)
(21min), and CH2Cl2 (31min), (2) prewash with
35% trifluoroacetic acid containing 1% thioanisole in
CH2Cl2 (11min), (3) shake resin with 35% TFA in
CH2Cl2 (30min), (4) wash with CH2Cl2 (21min), IPA
(11min), CH2Cl2 (21min), IPA (11min), CH2Cl2
(21min), (5) add the 15min preactivated solution of
Boc-amino acid (3 equiv, but 6 equiv for the third resi-
due), Bop reagent (3 equiv, but 6 equiv for the third
residue) and DIEA (6 equiv, but 12 equiv for the third
residue) in CH2Cl2 containing 10% DMF, pH of the
coupling reaction checked by using pH paper (more
DIEA added if necessary), shake mixture for 3–6 h. The
Kaiser ninhydrin test for free amine was performed
after step 1 to ensure that the coupling reaction was
complete. If positive (blue) is observed for step 1, then
either repeat step 5 until negative (yellow) result is
obtained or capping with acetic anhydride (10 equiv) in
CH2Cl2 for 1–2 h, (6) repeat step 1–5 for next coupling
reaction. The protected peptide fragment having N-
terminal Boc on was nucleophilic cleaved from the
oxime resin by using primary or secondary amines or
ammonium acetate in the presence of DIEA in DMF.
The peptide fragment was precipitated into a large
amount of water (25-times excess based on the peptide
volume). After filtration, the fragment was dried under
vacuum, Boc-deprotected by using 35% TFA in CH2Cl2
for 30min. After removing the TFA and CH2Cl2 under
reduced pressure, the peptide fragment was precipitated
in water, dried and primarily characterized by MALDI
MS. The fragment may be purified by reserve phase
HPLC when it is proved necessary by analytical HPLC.
General synthesis of symmetric parallel -sheet peptides
containing the dibenzofuran template via solution
segment condensation.48 A 25-mL round-bottomed flask
was charged with 0.2mmol of the peptide fragment,
0.07mmol of pentafluorophenyl ester 2, and 0.15mmol
of DIEA in 10–20mL of DMF. Additional DIEA was
added in mL quantities, if necessary, to raise the pH of
the reaction to pH 8–9 as monitored by moistened pH
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paper. The basic mixture was stirred at 25 C for 6–12 h.
The reaction was monitored by HPLC following loss of
the limiting reagent 2 and the appearance of a unique
peptide product as an indicator. After the reaction was
completed, the peptide was precipitated in a large
volume of water (500–700mL) and dried under vacuum.
The dried protected peptide crude was side-chain
deprotected by using catalytic transfer hydrogenation
with formic acid59,60 for peptides B, and D and HF61 for
peptides A, and C. All peptides were purified by reverse
phase C18 HPLC monitored at 254 nm and confirmed
by MALDI MS.
Synthesis of asymmetric parallel -sheet peptides
containing the dibenzofuran template via solid-phase
peptide synthesis. Asymmetrical template parallel sheet
sequences incorporating 1 were synthesized using a
fragment condensation between side chain protected
peptides covalently attached to the benzhydrylamine
and soluble peptide prepared on the p-nitrobenzoyl
oxime resin employing BOC chemistry. Fragment A
(R1–R5 and R1–R7, respectively) of peptides F and G
in the Table was synthesized on a low loading BHA resin
(0.2mequiv gÿ1) whereas oxime resin (0.5mequiv gÿ1
loading) was used for synthesizing fragment B (R6–R9
and R8–R13, respectively) of peptides F and G as
described. Ammonium acetate (10 equiv based on the
peptide loading) in the presence of DIEA (2 equiv) was
used to cleave the fragments o the oxime resin. The
Boc group at the N-terminus of fragment B was then
removed with a 35% TFA solution in CH2Cl2 (30min)
to yield the side-chain protected fragment containing a
free N-terminal amino group. The resulting fragment
R6–R9 of peptide F, having a free N-terminal amino
group, was purified by preparative C18 HPLC using a
linear gradient from 30–50% solvent B over 230 nm
while that of peptide G employed a gradient from 45–
72% solvent B over 20min, detected at 230 nm. Frag-
ment A of peptides F and G was synthesized using the
traditional solid-phase peptide synthesis strategy for
BHA resin.63 The BHA resin was pre-swollen in CH2Cl2
for 10min and washed with 12% DIEA in CH2Cl2
(25min) and CH2Cl2 (41min) prior to use. The first
amino acid was loaded onto the resin by shaking
1.2 equiv (based on 0.2mmol gÿ1 of the resin) of Boc-a-
amino acid and 1.2 equiv (based on 0.2mmol gÿ1 of the
resin) of DIC in CH2Cl2 for 24 h. The resin was washed
with CH2Cl2 (21min), DMF (21min), IPA
(11min), CH2Cl2 (21min), IPA (11min), and
CH2Cl2 (41min). The remaining unreacted amino
groups of the peptidyl-resin were acetylated by reacting
with acetic anhydride (30 equiv) in CH2Cl2. The follow-
ing cycle was used for each coupling: TFA prewash
(11min), TFA deprotection (150min), CH2Cl2
(21min), IPA (11min), CH2Cl2 (21min), IPA
(11min), and CH2Cl2 (41min), preneutralization
(12% DIEA, 11min), neutralization (12% DIEA,
19min), coupling (3 equiv of Boc-amino acid, 3 equiv
of Bop, 4 equiv of DIEA in CH2Cl2 containing 10–15%
DMF) for 2–5 h, DMF (21min), IPA (11min),
CH2Cl2 (21min), IPA (11min), and CH2Cl2
(41min). The completion of each coupling step was
monitored by the Kaiser ninhydrin test. If the result was
positive, the coupling reaction was repeated until the
Kaiser test became negative. The bis-pentafluorophenyl
ester 2 was employed to incorporate template 1 into the
peptide. The coupling was performed by shaking the
preneutralized resin with 3 equiv of bis-active ester 2
with 2 equiv of DIEA in CH2Cl2 containing 10%
DMF. Completion of the coupling step was again
monitored by the Kaiser ninhydrin test. Fragment B
(1.2 equiv) previously prepared on an oxime resin was
then coupled to the remaining pentafluorophenyl ester
(1 equiv) on the resin-bound peptide in the presence of
3 equiv DIEA in DMF for 24 h. Peptide E was pre-
pared on a regular loading BHA resin (0.5mequiv gÿ1).
The resin-bound peptide was then washed with warm
DMF (41min), CH2Cl2 (21min), dried under
vacuum and finally cleaved from the resin and side
chain deprotected by high HF.61 Fragment B of
peptide G was side-chain deprotected by catalytic
hydrogenation to aord crude peptide H. The crude
peptides were purified by preparative HPLC as descri-
bed earlier. All peptides were primarily confirmed by
MALDI MS.
Summary of purification and characterization of peptides
A–H
Peptide A (C58H90N10O11). Purification by preparative
C18 HPLC employing a linear gradient from 20–40%
solvent B over 20min: overall yield 32%; MALDI-
TOFMS (MH+) calcd 1103.4, obsd 1103.7.
Peptide B (C58H90N10O11). Purification by preparative
C18 HPLC employing a linear gradient from 25–45%
solvent over 20min: overall yield 52%; MALDI-
TOFMS (MH+) calcd 1103.4, obsd 1103.7.
Peptide C (C84H144N20O15). Purification by preparative
C18 HPLC employing a linear gradient from 20–50%
solvent B over 20min: overall yield 32%; MALDI-
TOFMS (MH+) calcd 1674.1, obsd 1674.0.
Peptide D (C80H136N20O17). Purification by preparative
C18 HPLC employing a linear gradient from 15–30%
solvent B over 22min: overall yield 10%; MALDI-
TOFMS (MH+) calcd 1650.0, obsd 1651.0.
Peptide E (C70H135N21O14). Purification by preparative
C18 HPLC employing a linear gradient from 0–45%
solvent B over 20min: overall yield 27%; MALDI-
TOFMS (MH+) calcd 1495.0, obsd 1495.1.
Peptide F (C65H107N13O11). Purification by preparative
C18 HPLC employing a linear gradient from 30–55%
solvent B over 20min: overall yield 10%; MALDI-
TOFMS (MH+) calcd 1246.8, obsd 1247.2.
Peptide G (C87H149N19O15). Purification by preparative
C18 HPLC employing a linear gradient from 30–50%
solvent B over 20min: overall yield 30%; MALDI-
TOFMS (MH+) calcd 1701.1, obsd 1701.0.
Peptide H (C35H70N10O6). Purification by preparative
C18 HPLC employing a linear gradient from 0–50%
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solvent B over 20min: overall yield 40%; MALDI-
TOFMS (MH+) calcd 727.5, obsd 727.0.
UV analysis. All UV spectra were collected on a Milton
Roy Spectronic 3000 diode array spectrophotometer
using a 10-mm quartz cell. The concentration of a pep-
tide stock solution was determined by using the diben-
zofuran chromophore at 282 nm (e=17,797 cmÿ1Mÿ1).
The peptide samples were prepared from stock solutions
in water and diluted to the appropriate concentration
with either 10mM acetate or 10mM borate buers
containing 75mM NaCl. All spectra are corrected for
buer or solvent contributions.
Circular dichroism studies. All CD spectra were per-
formed on AVIV 62A DS spectrometer employing
either a 1- (far-UV) or 10-mm (near-UV) quartz cell. The
samples were prepared from stock solutions in water
and diluted to the appropriate concentration with the
desired buer. The concentration of peptide samples
was determined by UV spectroscopy. The pH of each
sample was readjusted if necessary. The samples were
incubated at 25 C for at least 12 h. CD data were
acquired at a time constant of 4 s, a step size of 0.2 nm
and a bandwidth of 1 nm for far-UV CD (195–270 nm)
and at a time constant of 4 s, a step size of 0.5 nm, a
bandwidth of 1 nm and an average of two scans for
near-UV CD (240–320 nm). All spectra were corrected
for buer contributions and are reported in units of
mean residue ellipticity.79
pH Dependent CD studies. All peptide samples were
prepared as 0.1–0.8mM at a specific pH by dilution of
peptide stocks with 10mM acetate buers for pH 4–5.6,
10mM Tris buer for pH 7, or 10mM borate buer
for pH 8.0–8.9. The appropriate amount of NaCl was
included in each buer solution before the final pH of
the buer was measured. The CD spectrum of each
sample was recorded at 25 C in a 1-mm quartz cell
from 270–195 nm and in a 10-mm quartz cell from
320–240 nm.
Temperature dependent CD studies. All peptide samples
were prepared as described above. The samples were
incubated for at least 5–10min at each temperature
before data acquisition. The temperature was pro-
grammed to go from 40–1 C and then from 1–80 C
followed by a decrease of 80–40 C using 5 C increment
to establish reversibility in the change of the tempera-
ture dependent spectra.
FT IR studies. FT-IR spectroscopy was performed on
ATI-Mattson Galaxy Series 5000 or 6021 FT-IR spec-
trometer both equipped with a MCT detector. The
spectra were recorded at 2-cmÿ1 resolution and repre-
sent the average of 4096 scans each at 25 C. The spectra
were apodized with a triangular function before Fourier
transformation. All simple amide derivatives studied
were dried over P2O5 and refluxing toluene under high
vacuum for 2 days prior to use. The dichloromethane
for IR studies was freshly distilled from calcium
hydride. The concentration of all simple amides was
1.5mM. IR spectra were collected using a CaF2 solution
cell with an optical path length of 3mm. The spectra
were corrected for the contribution of dichloromethane
and baseline corrected. The peptide-TFA salt was con-
verted to the chloride salt by using a Dowex-21K anion
exchange resin in order to eliminate the TFA contribu-
tion in the amide I region. The concentration of the
peptide samples was determined by using the UV
absorption at 282 nm. The peptide samples were then
lyophilized, redissolved in deuterium oxide, and lyophi-
lized again in order to exchange amide protons for
deuteriums prior to analysis. The certain volume of
deuterium oxide was added to make up the concentra-
tion of the peptide samples (6–7 mM). The pH was
adjusted using DCl or NaOD solution. Alternatively the
peptides were dissolved in isopropanol freshly distilled
from calcium hydride. IR spectra of peptide samples
were performed using a CaF2 cell with a tin spacer of
15 mm. The spectra were corrected for spectral con-
tributions of D2O or isopropanol. Fourier self-decon-
volution (FSD) of the amide I and I0 regions was
performed with GRAMS/386 software using a resolu-
tion enhancement factor of 2.0–3.0 to aord a Lor-
entzian line-shape with full bandwidth at half-height
of 12–15 cmÿ1 after Bessel smoothing. Savitsky–Golay
second derivatives were taken with 11–30 convolution
points.
Analytical ultracentrifugation. The apparent molecular
weights of peptides in solution were obtained from
sedimentation equilibrium analysis. Sedimentation
equilibrium measurement were performed on a Beck-
man XL-A Analytical Ultracentrifuge equipped with a
An60Ti rotor, photoelectric scanner and a temperature
controlled system. Double sector aluminum centerpieces
and sapphire windows were used. The equilibrium dis-
tribution of the peptides was measured at 25 C or as
specified employing a rotor speed of 3,000–60,000 rpm
where sedimentation equilibrium is established. All
scans were performed at 280 nm or 230 nm depending
on the concentration of the peptides. Thirty scans were
averaged at each point with a step size of 0.001 cm.
Samples were allowed to equilibrate over 24–30 h and
duplicate scans 4 h apart were overlaid to determine
whether the equilibrium had been reached. The partial
specific volume was computed by Cohen and Edsall
method using partial specific volumes of individual
amino acid components at 25 C as previously pub-
lished.80 These values were adjusted for temperature
employing eq (1).
uT  u25  4:25 10ÿ4 Tÿ 25  1
The data were analyzed by a nonlinear least square
analysis using Origin Software provided by Beckman.
The data were then fit by using a single ideal species
model.81 The goodness of the fit was evaluated on the
basis of the randomness and magnitude of the residuals,
expressed as the dierence between the theoretical curve
and the experimental data, and by checking the fit
parameters for physical reasonability. For a monomeric
system, an attempt to fit the data to a self associated
model fails to give a good fit precluding the possibility
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of monomer n-mer equilibrium as an association model.
Transforming the equilibrium gradient (absorbance
versus radius) into a Mapp versus concentration plot
provides information about the association order of the
system. A complete loss of the initial absorbance is
indicative of a highly associated system. The samples
were prepared from stock solutions in water and
diluted to the desired concentration with 10mM desired
buer. The concentration of peptides were determined
by UV spectroscopy at 282 nm. The pH of each sample
was readjusted if necessary using either NaOH or HCl
solution.
NMR studies. The NMR spectra were recorded on a
Varian XL-400 or Unity Plus 500MHz NMR spectro-
meter at the temperature specified. All samples were
prepared as 1.5–3mM solutions in 10mM deuterated
acetate buered H2O/D2O (90/10) solution (pH 4.0).
The samples were degassed prior to NMR analysis by
sonication under a water aspirator vacuum. ROESY
and TOCSY data were recorded on a Varian Unity plus
500MHz NMR spectrometer using mixing times
between 150–300ms for ROESY and 70ms for TOCSY.
The amide H/D exchange experiments were carried out
on Varian Unity plus 500MHz NMR spectrometer
using a 8000Hz spectral width. The FID was the sum of
32 scans collected in 4096 complex points with an
acquisition time of 5-s and a 1-s recycle delay. Exchange
rate constants were determined from the least square fit
of a single exponential decay function. The peptide
samples were prepared by dissolving the peptide in
water to a concentration of 1–2mM and then lyophiliz-
ing to dryness. Exchange is initiated when the peptide is
dissolved, at 1–2mM in D2O containing 10mM deuter-
ated acetate buer (pD* 3.3). At least three exchange
experiments were carried out for each peptide to yield
an average rate constant (minÿ1).
Variable-temperature NMR studies. All amide deriva-
tives studied were dried under high vacuum in the pre-
sence of KOH for 2 days prior to use. The
concentration of the amides was 1.5mM in CD2Cl2
(Aldrich). Variable-temperature NMR measurements
were performed on Varian XL-400 or Varian Unity Plus
300 spectrometer using residual CHDCl2 (5.32 ppm) as
the chemical shift reference at all temperature.
Molecular dynamics/simulated annealing studies. A
molecular dynamics/simulated annealing experiment
was carried out using Biosym’s Insight II and Discover
modules, version v 2.3.0. The NOE cross peaks from
ROESY spectra and the amide H/D exchange rate from
NMR studies were used to constrain the structure. Each
NOE was assigned a distance range as a weak NOE
(1.8–5.0 A˚). Pseudoatoms were used in both the g-
methyl groups of the flanking Val residues and the 2,3
and 7,8 aromatic protons of the dibenzofuran ring.
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